| Old Articles: <Older 891-900 Newer> |
 |
Chemistry World February 2006 |
Editorial: Fighting Avian Flu Participants at a world avian flu conference in Beijing committed to increasing cooperation on global vaccine and anti-viral research and development.  |
Chemistry World January 31, 2006 Katharine Sanderson |
Sharing Out the Lab Measurement Billions Pharmaceutical measurement company Agilent Technologies has updated over 40% of its high pressure liquid chromatography and mass spectrometry ranges, and introduced software that can be used on competitor's machines.  |
ifeminists February 1, 2006 Wendy McElroy |
Questions to Ask Scientific Authority Stem cell research may be the most sensational and explosive scientific development of recent years. It also highlights the admonition, "Question Authority."  |
IEEE Spectrum February 2006 Samuel K. Moore |
Ajay Royyuru: Genographer In our genes: How this computational biologist traces the history of human migration through DNA data.  |
Reactive Reports Issue 51 David Bradley |
Protein Crystals Trapped Researchers have developed a new technique for crystallizing proteins, which could open up a whole range of materials to this powerful analytical technique.  |
Reactive Reports Issue 51 David Bradley |
Pond Scum Versus Alzheimer's Disease A compound isolated from the cyanobacterium Nostoc has revealed itself as a promising candidate for staving off the devastating symptoms of Alzheimer's disease.  |
Reactive Reports Issue 51 David Bradley |
Cannabinoids and Osteoporosis Researchers have discovered a regulatory mechanism involved in bone loss linked to a chemical receptor in our bodies with a previously unknown function, which could lead to a new treatment.  |
Science News January 28, 2006 Janet Raloff |
Born to Love Salt A new study finds that among normal-weight newborns, the smaller a baby is at birth, the more likely it is that he or she will show an early and strong preference for salty fare.  |
Scientific American February 2006 |
To Banish a Cancer Two vaccines that are nearing approval by the Food and Drug Administration in the U.S. have demonstrated in clinical trials that they can prevent infection from the two types of the human papillomavirus (HPV) that account for up to 70 percent of cervical cancers.  |
Scientific American February 2006 Steve Mirsky |
Bait and Switch Some notes on our feathered and finned friends  |
| <Older 891-900 Newer> Return to current articles. |